2016 Volume 62 Issue 6 Pages 718-728
In the survey conducted in 2015, among the 10,166 Japanese medical institutions receiving blood supply from the Japanese Red Cross Blood Center, the 5,261 institutions that responded to the questionnaire were enrolled, representing a response rate of 51.8%, the highest result in the past 8 annual surveys. Of the total supply from the Japanese Red Cross Society, 73.5% of the red blood cell products, 82.1% of the platelet concentrate, and 78.1% of the freshly frozen plasma were able to be investigated. Authorization to impose the blood transfusion management charge I and II increased in 476 and 1,234 institutions, respectively. Further, 1,215 institutions were able to impose the blood transfusion proper use addition (27.6%). The number of transfused patients is predicted to be 937,390 subjects for donated blood, and 114,473 subjects for autologous blood. Immunoglobulin product consumption increased this year as in the past few years. The amount of blood products consumed per sickbed varied greatly for each prefecture, suggesting the need to reconfirm appropriate blood transfusion management systems in each prefecture.
